Patrick Soon-Shiong, M.D., is a distinguished physician, surgeon, and scientist who currently holds the position of Global Chief Scientific and Medical Officer at IMMUNITYBIO INC. Born in South Africa, Dr. Soon-Shiong earned his medical degree from the University of the Witwatersrand and later completed his surgical training in the United States. His career has been marked by groundbreaking work in the fields of oncology and immunotherapy, earning him a reputation as a pioneer in medical innovation. Throughout his career, Dr. Soon-Shiong has made significant contributions to the field of medicine, particularly in the development of novel cancer therapies. He is best known for his work on Abraxane, a chemotherapy drug used to treat various types of cancer, which he developed and brought to market. His research has also focused on harnessing the power of the immune system to fight cancer, leading to the creation of several immunotherapy platforms. In recognition of his achievements, Dr. Soon-Shiong has received numerous awards and honors, including the National Medal of Technology and Innovation from President Barack Obama. As the Global Chief Scientific and Medical Officer at IMMUNITYBIO INC, Dr. Soon-Shiong plays a crucial role in guiding the company's research and development efforts. Under his leadership, IMMUNITYBIO is working to develop a range of innovative immunotherapies aimed at treating cancer and infectious diseases. Dr. Soon-Shiong's vision and expertise are instrumental in driving the company's mission to transform the landscape of medicine through cutting-edge science and technology.